Comparator supply for NCT02559778
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Sponsor: Giselle Sholler (OTHER). Phase: PHASE2. Status: Recruiting. Countries: United States, Canada. Last update posted 2026-09-04.
Registry record: https://clinicaltrials.gov/study/NCT02559778.
Canadian-labelled ceritinib
1 marketed Canadian product(s) from 1 manufacturer(s) contain ceritinib. Available strengths: 150 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled dasatinib
11 marketed Canadian product(s) from 2 manufacturer(s) contain dasatinib. Available strengths: 100 MG, 140 MG, 20 MG, 50 MG, 70 MG, 80 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled sorafenib
1 marketed Canadian product(s) from 1 manufacturer(s) contain sorafenib (sorafenib tosylate). Available strengths: 200 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
Canadian-labelled vorinostat
1 marketed Canadian product(s) from 1 manufacturer(s) contain vorinostat. Available strengths: 100 MG. Because the comparator is registered in Canada, supply can be arranged without a Special Access request and with the Canadian label, package insert and lot documentation the protocol expects.
What we supply
- Canadian-labelled comparator sourced through licensed Canadian supply
- Certificate of Analysis for every batch
- Batch number and expiry documentation, with retained records
- Blinding-ready packaging and over-encapsulation on request
- 2–8 °C validated cold chain with temperature logging where required
- Health Canada Drug Establishment Licence #3-002896
Frequently asked questions
Can Nexara supply Canadian-labelled ceritinib as a trial comparator?
Yes. We source Canadian-marketed ceritinib under Health Canada Drug Establishment Licence #3-002896 and ship it with Certificate of Analysis, batch number and expiry documentation for use as a comparator or rescue supply in NCT02559778.
What documentation comes with each shipment?
Certificate of Analysis, manufacturer batch and expiry records, chain-of-custody documentation from the Canadian supply chain, and temperature records where cold chain applies. Blinding-ready packaging is available on request.
How long does comparator supply take?
Quotes are returned within one business day. Lead time depends on the presentation and the destination country's import route — typically 10 to 21 days once the importer's licence and any notification are in place.
Request comparator quote
Request comparator quote or call +1-431-588-9055.